Clinical Trial Update: A Clinical Study on the Efficacy and Safety of Methotrexate (MTX) or Thiotepa (for MTX Intolerance) or Temozolomide (TMZ) Combined With Orelabrutinib and Selinexor in Relapsed/Refractory Primary or Secondary Central Nervous System Lymphoma（SELINA） [NA]

View source ↗

Summary

Clinical trial evaluating the efficacy and safety of combining methotrexate or thiotepa or temozolomide with orelabrutinib and selinexor in relapsed/refractory …

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Central Nervous System Lymphoma

Drugs mentioned

• METHOTREXATE (METHOTREXATE)
• Orelabrutinib (orelabrutinib)
• Selinexor (selinexor)
• THIOTEPA (THIOTEPA)
• Temozolomide (Temozolomide)

Snippet

Sponsor: Ruijin Hospital | Conditions: Lymphoma Cns | NA | Status: RECRUITING